Borowiec, A., Właszczuk, A., Olakowska, E. and Lewin-Kowalik, J. 2022. TXNIP inhibition in the treatment of diabetes. Verapamil as a novel therapeutic modality in diabetic patients. Medicine and Pharmacy Reports. 95, 3 (Jun. 2022), 243-250. DOI:https://doi.org/10.15386/mpr-2187.